Condensed Consolidated Statements of Earnings (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Statement [Abstract]
Net Sales	$ 1,892.4	$ 1,836.7	$ 5,856.5	$ 5,861.9
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization	$ 535.7	$ 529.0	$ 1,670.4	$ 1,688.5
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Intangible asset amortization	$ 146.6	$ 147.6	$ 436.9	$ 447.9
Research and development	114.4	95.7	328.2	290.5
Selling, general and administrative	830.1	787.7	2,466.8	2,380.7
Intangible asset impairment		3.8	70.1	3.8
Acquisition, integration and related	(0.9)	17.4	20.3	113.9
Quality remediation	20.7	32.2	63.1	112.3
Operating expenses	1,646.6	1,613.4	5,055.8	5,037.6
Operating Profit	245.8	223.3	800.7	824.3
Other expense, net	(4.4)	(2.2)	(9.6)	(8.7)
Interest expense, net	(56.8)	(67.5)	(174.5)	(220.8)
Earnings before income taxes	184.6	153.6	616.6	594.8
(Benefit) provision for income taxes	(247.4)	(8.5)	(193.5)	71.6
Net Earnings	432.0	162.1	810.1	523.2
Less: Net earnings (loss) attributable to noncontrolling interest	0.9	(0.1)	(0.8)	1.3
Net Earnings of Zimmer Biomet Holdings, Inc.	$ 431.1	$ 162.2	$ 810.9	$ 521.9
Earnings Per Common Share
Basic	$ 2.10	$ 0.80	$ 3.96	$ 2.57
Diluted	$ 2.08	$ 0.79	$ 3.93	$ 2.55
Weighted Average Common Shares Outstanding
Basic	205.3	203.7	204.8	203.3
Diluted	207.0	205.4	206.3	204.9